Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Icebrg who wrote (312)	10/26/2005 8:41:07 PM
From: tom pope	Respond to of 362

He has been a director of Titan Pharmceuticals since October 1995. In other words, from day one. The gentleman has seen good days and bad days since he joined the company. Let's hope this buy is a harbinger of better things to come: stockcharts.com[d,a]maclyiay[d19951002,20051026][pb50!b200][vc60][iUh14,3!La12,26,9!Lc20]&pref=G

To: Icebrg who wrote (312)	10/26/2005 11:03:22 PM
From: kenhott	Read Replies (1) \| Respond to of 362

TTP burned my backside nice and well so I would normally just look the other way fast and walk on by. But them be kind of curious. Allen, Bucalo, Farrell, and Huckle.... not a lot of money, but one from each column. You have any wild guess as to what possible company info/event someone may think they are trading on? Of course it can always be an attempt to display confidence. Other than Bucalo, the others are all in the low $100k for holdings. I see TTP burned thru all that cash and now has $24m left. And they have a deal with Cornell for more cash for shares. Did all the purchases go off before Sept 29th? But then I wouldn't think Cornell would care all that much about this kind of window dressing. Interesting find.